Owkin is an AI biotech company that uses artificial intelligence to identify new treatments, optimize clinical trials and develop AI diagnostics. The...

the company announced it would be investing $180m in French AI company Owkin, to design potentially more precise and efficient clinical trials. The collaboration...

$10.8 billion. In December 2023, Merck announced it had partnered with Owkin to develop artificial intelligence-powered digital pathology diagnostics...

reported that Sanofi would be investing $180 million in French startup Owkin, whose predictive algorithms aim to improve the research and development...